At Adalid, we are dedicated to advancing pharmaceutical solutions through the development of novel lipid nanoparticle technology. By leveraging LNPs, we aim to enhance the stability and bioavailability of drugs, improving their therapeutic efficacy while minimizing potential side effects. Our team has accumulated decades of expertise in using lipid nanoparticles as a delivery system for nucleic acids and related fields. With our strong background in synthetic chemistry, biochemistry, and nanoparticle formulation, we can provide added value and seamlessly integrate into our clients' workflows.